In adult patients with primary hyperlipidemia or mixed dyslipidemia, lower increased levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG), and apolipoprotein B (Apo B) and raise high-density lipoprotein cholesterol (HDL-C).